A patient will begin treatment with posaconazole [Noxafil] to treat oropharyngeal candidiasis that has not responded to fluconazole. The provider has ordered 200 mg 3 times daily. Which action by the nurse is correct?

Question

Quizplus · Accepted Answer

When given for treatment of oropharyngeal candidiasis that is refractory to treatment with itraconazole or fluconazole, the dose is 400 mg twice daily. A dosage regimen of 200 mg 3 times daily is used for prophylaxis of invasive fungal infections and decreasing this to twice daily is not correct.

A Patient Will Begin Treatment with Posaconazole [Noxafil] to Treat